Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Rappa, Alessandra"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal Dysplasia.
    Autorzy:
    Chu F; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Maffini F; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Lepanto D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Taormina SV; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    De Berardinis R; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Gandini S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
    Vignati S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
    Ranghiero A; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
    Rappa A; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
    Chiocca S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
    Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Tagliabue M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
    Ansarin M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 Feb 09; Vol. 15 (4). Date of Electronic Publication: 2023 Feb 09.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2- Breast Cancer.
    Autorzy:
    Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Pepe F; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
    Munzone E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Sajjadi E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Russo G; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
    Pisapia P; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
    Ivanova M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Bonizzi G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Taormina SV; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Troncone G; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
    Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.
    Guerini-Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Malapelle U; Department of Public Health, Federico II University of Naples, Via S. Pansini, 5, 80131 Naples, Italy.
    Fusco N; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Pokaż więcej
    Źródło:
    Cells [Cells] 2022 Nov 09; Vol. 11 (22). Date of Electronic Publication: 2022 Nov 09.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms*/genetics
    Breast Neoplasms*/pathology
    Humans ; Female ; Paraffin Embedding/methods ; Reverse Transcriptase Polymerase Chain Reaction ; Biomarkers, Tumor/genetics ; Class I Phosphatidylinositol 3-Kinases/genetics ; High-Throughput Nucleotide Sequencing/methods ; Formaldehyde
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive Patients.
    Autorzy:
    Fumagalli C; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Diagnostic Services, Division of Pathology, Azienda Socio Sanitaria Territoriale (ASST) Valle Olona, 21013 Gallarate, Italy.
    Betella I; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
    Rappa A; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
    di Giminiani M; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Health Sciences, University of Milan, 20122 Milan, Italy.
    Gaiano M; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Obstetrics and Gynaecology Unit, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
    De Vitis LA; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Health Sciences, University of Milan, 20122 Milan, Italy.
    Zambetti B; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Obstetrics and Gynaecology Unit, Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.
    Vacirca D; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
    Multinu F; Division of Gynecologic Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
    Venetis K; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
    Colombo N; Division of Gynecologic Oncology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; School of Medicine and Surgery, Università degli Studi di Milano-Bicocca, 20126 Milan, Italy.
    Barberis M; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.
    Guerini Rocco E; Clinical Unit of Oncogenomics, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2022 Mar 23; Vol. 14 (7). Date of Electronic Publication: 2022 Mar 23.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.
    Autorzy:
    Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Porta FM; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; School of Pathology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Rappa A; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Guerini-Rocco E; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Viale G; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Barberis M; Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
    Catania C; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
    Pokaż więcej
    Źródło:
    Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Aug 31; Vol. 28 (5), pp. 3384-3392. Date of Electronic Publication: 2021 Aug 31.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
    MeSH Terms:
    Adenocarcinoma of Lung*/diagnosis
    Adenocarcinoma of Lung*/drug therapy
    Adenocarcinoma of Lung*/genetics
    Breast Neoplasms*/diagnosis
    Breast Neoplasms*/genetics
    Lung Neoplasms*/diagnosis
    Lung Neoplasms*/genetics
    Diagnosis, Differential ; ErbB Receptors/genetics ; Female ; Humans ; Mutation
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Author Correction: A role for the immune system in advanced laryngeal cancer.
    Autorzy:
    Tagliabue M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy. .
    Maffini F; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Fumagalli C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Gandini S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
    Lepanto D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Corso F; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
    Cacciola S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Cossu Rocca M; Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Alterio D; Division of Radiotherapy, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Guerini Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy.
    Cattaneo A; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Chu F; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Zorzi S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Curigliano G; Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Chiocca S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
    Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato‑Oncology, School of Medicine, State University of Milan, Milan, Italy.
    Ansarin M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2021 May 03; Vol. 11 (1), pp. 9760. Date of Electronic Publication: 2021 May 03.
    Typ publikacji:
    Published Erratum
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations.
    Autorzy:
    Passaro A; Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Attili I; Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Rappa A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Vacirca D; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Ranghiero A; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Fumagalli C; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Guarize J; Department of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Spaggiari L; Department of Thoracic Surgery, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
    de Marinis F; Division of Thoracic Oncology, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Barberis M; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
    Guerini-Rocco E; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 Apr 30; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 30.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A role for the immune system in advanced laryngeal cancer.
    Autorzy:
    Tagliabue M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy. .
    Maffini F; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Fumagalli C; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Gandini S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
    Lepanto D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Corso F; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
    Cacciola S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Ranghiero A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Rappa A; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Vacirca D; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Cossu Rocca M; Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Alterio D; Division of Radiotherapy, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Guerini Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, School of Medicine, State University of Milan, Milan, Italy.
    Cattaneo A; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Chu F; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Zorzi S; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Curigliano G; Department of Oncology and Hemato-Oncology, School of Medicine, State University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Chiocca S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.
    Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, School of Medicine, State University of Milan, Milan, Italy.
    Ansarin M; Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Oct 27; Vol. 10 (1), pp. 18327. Date of Electronic Publication: 2020 Oct 27.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Laryngeal Neoplasms/*immunology
    Aged ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Immunity/genetics ; Immunity/immunology ; Laryngeal Neoplasms/diagnosis ; Laryngeal Neoplasms/pathology ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/metabolism ; Prognosis ; Retrospective Studies ; Sequence Analysis, RNA
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy.
    Autorzy:
    Fumagalli C; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .
    Tomao F; Department of Obstetric, Gynecologic and Urologic Sciences, University of Rome 'Sapienza', 00161 Rome, Italy. .
    Betella I; Division of Gynecologic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
    Rappa A; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. alessandra.rappa@ieo.it.
    Calvello M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
    Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
    Bernard L; Clinical Genomics Lab, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
    Peccatori F; Division of Gynecologic Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .
    Colombo N; Division of Gynecologic Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy. .; School of Medicine and Surgery, Università degli Studi di Milano-Bicocca, 20126 Milan, Italy. .
    Viale G; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy. .
    Barberis M; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .
    Guerini-Rocco E; Division of Pathology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20141 Milan, Italy. .; Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy. .
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2019 Oct 24; Vol. 11 (11). Date of Electronic Publication: 2019 Oct 24.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A case of Warthin-like papillary thyroid carcinoma with diffuse sclerosing stroma and a novel RET mutation: a new entity or a combined tumour?
    Autorzy:
    Maffini F; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.; These authors contributed equally to writing this article.
    Lorenzini D; University of Milan School of Medicine, Via Ripamonti 435, 20141 Milan, Italy.; These authors contributed equally to writing this article.
    Lepanto D; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
    De Fiori E; Department of Radiology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
    Fumagalli C; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
    Rappa A; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
    Tagliabue M; Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
    Barberis M; Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
    Pokaż więcej
    Źródło:
    Ecancermedicalscience [Ecancermedicalscience] 2019 Oct 02; Vol. 13, pp. 965. Date of Electronic Publication: 2019 Oct 02 (Print Publication: 2019).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Enhanced expression of Stim, Orai, and TRPC transcripts and proteins in endothelial progenitor cells isolated from patients with primary myelofibrosis.
    Autorzy:
    Dragoni S; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Laforenza U; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
    Bonetti E; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
    Reforgiato M; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Poletto V; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
    Lodola F; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Bottino C; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
    Guido D; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Rappa A; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Pareek S; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Tomasello M; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Guarrera MR; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Cinelli MP; Department of Public Health, University of Naples 'Federico II', Naples, Italy.
    Aronica A; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
    Guerra G; Department of Health Sciences, University of Molise, Campobasso, Italy.
    Barosi G; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
    Tanzi F; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Rosti V; Centre for the Study of Myelofibrosis, Laboratory of Biotechnology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy.
    Moccia F; Laboratory of General Physioloy, Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Pavia, Italy.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Mar 06; Vol. 9 (3), pp. e91099. Date of Electronic Publication: 2014 Mar 06 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Calcium Channels/*metabolism
    Endothelial Progenitor Cells/*metabolism
    Membrane Proteins/*metabolism
    Primary Myelofibrosis/*genetics
    Primary Myelofibrosis/*pathology
    TRPC Cation Channels/*metabolism
    Adenosine Triphosphate/pharmacology ; Adult ; Aged ; Anilides/pharmacology ; Calcium/metabolism ; Calcium Channels/genetics ; Cell Proliferation/drug effects ; Cell Separation ; Colony-Forming Units Assay ; Endoplasmic Reticulum/drug effects ; Endoplasmic Reticulum/metabolism ; Endothelial Progenitor Cells/drug effects ; Female ; Gadolinium/pharmacology ; Humans ; Indoles/pharmacology ; Inositol 1,4,5-Trisphosphate/metabolism ; Intracellular Space/drug effects ; Intracellular Space/metabolism ; Lanthanum/pharmacology ; Male ; Membrane Potentials/drug effects ; Membrane Proteins/genetics ; Middle Aged ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction/drug effects ; TRPC Cation Channels/genetics ; Thiadiazoles/pharmacology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies